Complete response for advanced liver cancer during sorafenib therapy: Case Report

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common neoplasia in the world. In the past, treatment of advanced HCC with conventional antineoplastic drugs did not result in satisfactory outcomes: recently, in this patient population the oral multikinase inhibitor sorafenib has been ab...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sacco, Rodolfo, Bargellini, Irene, Gianluigi, Giannelli, Bertini, Marco, Bozzi, Elena, Altomare, Emanuele, Battaglia, Valentina, Romano, Antonio, Bertoni, Michele, Capria, Alfonso, Bresci, Giampaolo, Bartolozzi, Carlo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3036648/
https://ncbi.nlm.nih.gov/pubmed/21241463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-11-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi